{
  "nctId": "NCT03450655",
  "briefTitle": "Cardio Training of Older Adults With Central Obesity",
  "officialTitle": "Cardio Training of Older Adults With Central Obesity",
  "protocolDocument": {
    "nctId": "NCT03450655",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2018-02-16",
    "uploadDate": "2018-02-16T08:30",
    "size": 309095,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT03450655/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "SINGLE",
  "enrollmentInfo": {
    "enrollmentCount": 80,
    "enrollmentType": "ESTIMATED"
  },
  "timeline": {
    "startDate": "2018-02-09",
    "completionDate": "2018-09-28",
    "primaryCompletionDate": "2018-09-28",
    "firstSubmitDate": "2018-02-16",
    "firstPostDate": "2018-03-01"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Participated in the Healthy Ageing Initiative (a population-based intervention study in Umeå, Sweden)\n* Visceral adipose tissue mass \\>1 kg (women) or \\>2 kg (men)\n\nExclusion Criteria:\n\n* Physical disability that affects ability to perform the exercises\n* Heart failure or severe degenerative condition (e.g. malignant cancer or multiple sclerosis)\n* Myocardial infarction or stroke in the past year\n* Heart condition that can worsen with aerobic exercise (e.g. angina)",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "70 Years",
    "maximumAge": "70 Years",
    "stdAges": [
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Change in visceral adipose tissue mass",
        "description": "Mass (g) measured using Lunar iDXA with CoreScan application (GE Healthcare, Wauwatosa, WI, USA).",
        "timeFrame": "0, 10, 20, and 31 weeks"
      }
    ],
    "secondary": [
      {
        "measure": "Change in body composition",
        "description": "Mass (g) measured using Lunar iDXA with CoreScan application (GE Healthcare, Wauwatosa, WI, USA)",
        "timeFrame": "0, 10, 20, and 31 weeks"
      },
      {
        "measure": "Change in Body Mass Index (kg/m^2)",
        "timeFrame": "0, 10, 20, and 31 weeks"
      },
      {
        "measure": "Change in blood pressure (mmHg)",
        "description": "Taken after 15 min of rest",
        "timeFrame": "0, 10, 20, and 31 weeks"
      },
      {
        "measure": "Change in blood-lipid profile",
        "timeFrame": "0, 10, 20, and 31 weeks"
      },
      {
        "measure": "Change in fasting blood glucose",
        "description": "Veinous blood samples taken after \\> 4 h of fasting",
        "timeFrame": "0, 10, 20, and 31 weeks"
      },
      {
        "measure": "Change in isometric muscle strength",
        "description": "Measured in non-dominant hand with dynamometer (Jamar, Lafayette Instrument, USA). The better of two successive trials will be recorded.",
        "timeFrame": "0, 10, 20, and 31 weeks"
      },
      {
        "measure": "Change in physical capacity",
        "description": "Measured using Åstrands Submaximal Test, performed on an electrically braked ergometer bicycle",
        "timeFrame": "0, 10, 20, and 31 weeks"
      },
      {
        "measure": "Change in resting metabolic rate",
        "description": "As measured by indirect calorimetry",
        "timeFrame": "0, 10, 20, and 31 weeks"
      },
      {
        "measure": "Change in health-related quality of life",
        "description": "As measured by RAND-36",
        "timeFrame": "0, 10, 20, and 31 weeks"
      },
      {
        "measure": "Change in self-reported physical activity",
        "description": "Assessed using IPAQ-SF",
        "timeFrame": "0, 10, 20, and 31 weeks"
      },
      {
        "measure": "Change in Microbiota composition",
        "description": "Fecal samples are taken and bacterial DNA is sequenced to determine bacterial composition",
        "timeFrame": "0, 10, 20, and 31 weeks"
      },
      {
        "measure": "Change in dietary habits",
        "description": "85 item food frequency questionnaire",
        "timeFrame": "0, 10, 20, and 31 weeks"
      },
      {
        "measure": "Change in concentration of inflammatory markers",
        "timeFrame": "0, 10, 20, and 31 weeks"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 13,
      "otherCount": 0,
      "totalCount": 14
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 100,
    "complexityCategory": "Highly Complex"
  },
  "collectionDate": "2025-09-22T02:30:16.422Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}